iwCLL 2019 | The DUO trial: dose modifications on response to duvelisib in patients with SLL/CLL

Paolo Ghia

Paolo Ghia, MD, PhD, IRCCS, San Raffaele Scientific Institute, Milan, Italy, talks about the DUO trial (NCT02004522) looking at the effect of dose modifications on the response to duvelisib in patients with SLL/CLL. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video